Overlook Medical Center

Cancer Hope Network and Atlantic Health System Announce Collaboration To Launch New Breast Cancer Peer Support Program

Retrieved on: 
Wednesday, March 20, 2024
Diagnosis, RN, Breast cancer, Organization, Growth, Mentorship, Caregiver, Atlantic Health System, Partnership, Patient, Cancer, Volunteering, Morristown Medical Center, Overlook Medical Center, Social work, Estate (law)

CHESTER, N.J, and MORRISTOWN, N.J., March 20, 2024 /PRNewswire-PRWeb/ -- Cancer Hope Network and Atlantic Health System are proud to announce a new partnership that will establish a Breast Cancer Peer Support Program across all Atlantic Health System oncology facilities. This collaborative initiative matches patients receiving care for breast cancer at Atlantic Health System with a trained peer mentor who has been through a similar cancer experience, while also offering a platform for cancer survivors to give back to their community by volunteering as peer mentors.

Key Points: 
  • CHESTER, N.J, and MORRISTOWN, N.J., March 20, 2024 /PRNewswire-PRWeb/ -- Cancer Hope Network and Atlantic Health System are proud to announce a new partnership that will establish a Breast Cancer Peer Support Program across all Atlantic Health System oncology facilities.
  • "Atlantic Health System is committed to helping our patients along every step of their cancer journey" said Lydia Nadeau, RN, Executive Director, Atlantic Health System Cancer Care.
  • In addition to the recruitment, onboarding and initial training of volunteers, Atlantic Health System and Cancer Hope Network will provide ongoing training to ensure volunteers can provide effective support to newly diagnosed breast cancer patients.
  • The Breast Cancer Peer Support Program underscores the shared vision of Cancer Hope Network and Atlantic Health System to enhance patient-centered care and promote survivorship beyond medical treatment.

The Inner Circle acknowledges Nana E. Tchabo, MD, FACOG as a Pinnacle Life Member

Retrieved on: 
Thursday, March 7, 2024
Theta, Overlook Medical Center, Woman, Professional, Inner circle, Doctor of Philosophy, Multimedia, MD, Georgetown University, Education, Immunotherapy, Pathology, Thomas Jefferson University, Uterine cancer, ABOG, Parent, Principal investigator, Radiation, National Cancer Institute, Women's studies, Gynecologic Oncology (journal), Health, FACOG, Oncology nursing, Brown University, Vaginal cancer, Ovarian cancer, Associate, Gestational trophoblastic disease, Women's health, Biology, Mount Sinai School, Estate (law), Delta Sigma, Research, Carol, Medication

CHESTER, N.J., March 7, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Nana E. Tchabo, MD, FACOG, is acknowledged as a Pinnacle Life Member for her contributions to the field of Gynecologic Oncology.

Key Points: 
  • CHESTER, N.J., March 7, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Nana E. Tchabo, MD, FACOG, is acknowledged as a Pinnacle Life Member for her contributions to the field of Gynecologic Oncology.
  • Dr. Tchabo pursued higher education at Brown University where she received a Bachelor of Science in Neuroscience and a minor in Women's Studies.
  • She then attended the Warren Alpert Brown University School of Medicine, where she was cited for academic excellence.
  • Dr. Tchabo currently works at Atlantic Women's Cancer Associates, a part of Atlantic Health System Morristown and Overlook Medical Centers.

The Inner Circle Acknowledges, Nana E. Tchabo, MD, FACOG as a Pinnacle Life Member for her contributions to the field of Gynecologic Oncology

Retrieved on: 
Monday, November 13, 2023
Theta, Inner circle, Georgetown University, Brown University, Woman, Oncology nursing, Associate, Reproductive Sciences, Research, Radiation, Cervical cancer, Gynecologic Oncology (journal), Overlook Medical Center, Pathology, National Cancer Institute, Roswell Park, Mount Sinai School, Women's studies, Multimedia, Professional, Fellow, Thomas Jefferson University, Vaginal cancer, Medication, Health, Alpert Medical School, Vulvar cancer, ABOG, Uterine cancer, Exceptional Women in Publishing, Ovarian cancer, MD, Japanese Cancer Association, FACOG, Delta Sigma, Women's health, Atlantic Women's Colleges Conference, Carol, Volunteering, Flexner Report, Estate (law), Biology, Education, Birth control, Science, Gynaecology, Medicine, Cancer, New York (magazine), Neuroscience, Obstetrics

CHESTER, N.J., Nov. 13, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Nana E. Tchabo, MD, FACOG, is acknowledged as a Pinnacle Life Member for her contributions to the field of Gynecologic Oncology.

Key Points: 
  • CHESTER, N.J., Nov. 13, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Nana E. Tchabo, MD, FACOG, is acknowledged as a Pinnacle Life Member for her contributions to the field of Gynecologic Oncology.
  • Dr. Tchabo pursued higher education at Brown University where she received a Bachelor of Science in Neuroscience, minoring in Women's Studies.
  • She then attended the Warren Alpert Medical School of Brown University for her medical degree, where she was cited for academic excellence.
  • Dr. Tchabo currently works at Atlantic Women's Cancer Associates, a part of Atlantic Health Systems Morristown and Overlook Medical Centers.

Roswell Park Cancer Innovation SurVaxM Granted FDA Fast Track Designation

Retrieved on: 
Saturday, October 14, 2023
Multimedia, M&T Bank, Priority review, Cancer, Glomus tumor, Food, Doctor of Philosophy, Hope, Research, Roswell Park Comprehensive Cancer Center, Texas Oncology, Ride, Multiple myeloma, Roswell, MD, Fred Hutchinson Cancer Research Center, National Cancer Institute, University, Survival, Disease, FDA, Glioblastoma, Accelerated approval (FDA), Fast track (FDA), NDA, Neurosurgery, Overlook Medical Center, Northwell Health, Journal, FTD, Fast Track, Assistant, PSA, Regulation of tobacco by the U.S. Food and Drug Administration, American Journal of Clinical Oncology, Principal investigator, Prostate cancer, Brain, Patient, Cleveland Clinic, Dana–Farber Cancer Institute, Pharmaceutical industry, Medical imaging, Medical device, Online shopping, DRS, Upstate New York, New York University, Roswell Park

BUFFALO, N.Y., Oct. 14, 2023 /PRNewswire-PRWeb/ -- A promising cancer innovation developed at Roswell Park Comprehensive Cancer Center has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration (FDA). The designation awarded to MimiVax Inc. provides more extensive and accelerated access to FDA resources for the company's development of the novel cancer immunotherapy SurVaxM, which is now in late-stage trials around the country.

Key Points: 
  • The designation awarded to MimiVax Inc. provides more extensive, accelerated access to FDA resources supporting development of SurVaxM, which originated at Roswell Park.
  • BUFFALO, N.Y., Oct. 14, 2023 /PRNewswire-PRWeb/ -- A promising cancer innovation developed at Roswell Park Comprehensive Cancer Center has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration (FDA).
  • From the world's first chemotherapy research to the PSA prostate cancer biomarker, Roswell Park Comprehensive Cancer Center generates innovations that shape how cancer is detected, treated and prevented worldwide.
  • To learn more about Roswell Park Comprehensive Cancer Center and the Roswell Park Care Network, visit http://www.roswellpark.org , call 1-800-ROSWELL (1-800-767-9355) or email [email protected] .

MimiVax Granted Fast Track Designation from FDA for SurVaxM for Newly Diagnosed Glioblastoma

Retrieved on: 
Thursday, October 12, 2023
Priority review, Texas Oncology, UCSF, Fred Hutchinson Cancer Research Center, Disease, FDA, Science in newly industrialized countries, Accelerated approval (FDA), NDA, Overlook Medical Center, Journal, Northwell Health, FTD, Fast Track, NYU, American Journal of Clinical Oncology, Roswell Park, Patient, Cleveland Clinic, Dana–Farber Cancer Institute, Pharmaceutical industry, Medical device, Glioblastoma

BUFFALO, N.Y., Oct. 12, 2023 /PRNewswire/ -- MimiVax, Inc. , a biotechnology company focused on the development of glioblastoma vaccine therapy, announced today that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to MimiVax's SurVaxM vaccine being studied for the treatment of newly diagnosed glioblastoma (nGBM).

Key Points: 
  • BUFFALO, N.Y., Oct. 12, 2023 /PRNewswire/ -- MimiVax, Inc. , a biotechnology company focused on the development of glioblastoma vaccine therapy, announced today that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to MimiVax's SurVaxM vaccine being studied for the treatment of newly diagnosed glioblastoma (nGBM).
  • MimiVax Granted Fast Track Designation from FDA for SurVaxM for Newly Diagnosed Glioblastoma.
  • MimiVax is focused on completing the Phase 2b SURVIVE study and securing funding necessary to bring SurVaxM through the FDA approval process.
  • "The receipt of Fast Track Designation affirms the importance of new clinical developments of novel therapies to improve the treatment and outcomes for patients with newly diagnosed glioblastoma," said Michael Ciesielski, CEO of MimiVax.

The Inner Circle Acknowledges, Joseph P. Calderone as a Top Pinnacle Healthcare Professional for his contributions to the field of Ophthalmology

Retrieved on: 
Friday, September 1, 2023
Seton Hall University School of Law, Medicine, College, Refractive surgery, American Board of Ophthalmology, ABO, Surgery, Central Jersey, Fellow of the American College of Surgeons, Holy Cross, Regius Professor, Graduate medical education, American Academy, American Academy of Ophthalmology, Multimedia, Cataract, New York Medical College, New Jersey Academy of Science, Albany Medical Center, Inner circle, American Society of Cataract and Refractive Surgery, American Board of Commissioners for Foreign Missions, Patient, Physician, Betancourt v. Trinitas Hospital, New Jersey Medical School, American College, Overlook Medical Center, Catali (footballer), Family, Society, Nursing, Ophthalmology, Chemistry

CRANFORD, N.J., Sept. 1, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Joseph P. Calderone is acknowledged as a Top Pinnacle Healthcare Professional for his contributions to the field of Ophthalmology.

Key Points: 
  • CRANFORD, N.J., Sept. 1, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Joseph P. Calderone is acknowledged as a Top Pinnacle Healthcare Professional for his contributions to the field of Ophthalmology.
  • Dr. Calderone began his scholarship at the College of the Holy Cross where he graduated with a Bachelor of Arts degree in Chemistry.
  • The doctor currently works as the Medical and Surgical Director of Better Vision New Jersey (formerly called Cranford Ophthalmology) where he has served since 1987.
  • Dr. Calderone would like to dedicate this honor in loving memory of his father, Joseph P. Calderone, and thanks his wife Heidi, and daughters.

American Osteopathic Association installs Ira P. Monka, DO, as 127th President

Retrieved on: 
Thursday, July 27, 2023
Osteopathic medicine in Canada, DOS, Osteopathic medicine in the United States, University, Emergency medicine, Internal medicine, House of Delegates, American Osteopathic Association, Pediatrics, Quality of life, Medicine, Research, 127th, Atlantic Health System, AOA, Rowan-Virtua School of Osteopathic Medicine, American Osteopathic Board of Emergency Medicine, Osteopathy, DO, American Osteopathic Board of Family Physicians, Patient, Overlook Medical Center, Physician, School, New Jersey Association of Independent Schools, Surgeon, Certification, Delegate, Dentistry, Empathy, Health, House, Anesthesiology, Nursing

CHICAGO, July 27, 2023 /PRNewswire/ -- The American Osteopathic Association (AOA) inaugurated Ira P. Monka, DO, FACOFP, as its 127th president during its annual House of Delegates meeting on July 22.

Key Points: 
  • CHICAGO, July 27, 2023 /PRNewswire/ -- The American Osteopathic Association (AOA) inaugurated Ira P. Monka, DO, FACOFP, as its 127th president during its annual House of Delegates meeting on July 22.
  • For nearly four decades, Dr. Monka has served patients through the Atlantic Health System in New Jersey as an osteopathic board-certified family physician.
  • As an osteopathic family physician, Dr. Monka has dedicated his entire career to serving patients on the frontlines of health care.
  • Dr. Monka, who is board-certified by the American Osteopathic Board of Family Physicians, took time during his inaugural address to stress the importance of maintaining the distinctiveness of osteopathic medicine.

MimiVax Announces Positive Final Data from the Phase IIa Study of SurVaxM for Newly Diagnosed Glioblastoma Published Today in the Journal of Clinical Oncology

Retrieved on: 
Thursday, December 15, 2022
Journal of Clinical Oncology, Beth Israel Deaconess Medical Center, Science in newly industrialized countries, Phase, Recurrence, Dana–Farber Cancer Institute, Oncology, Overlook Medical Center, MD, Baptist Health, Immunotherapy, American Journal of Clinical Oncology, Fred Hutchinson Cancer Research Center, Doctor of Philosophy, Diagnosis, Cleveland Clinic, UCSF Medical Center, Progression-free survival, Patient, JCO, Roswell Park Comprehensive Cancer Center, Survivin, NYU Langone Health, Hospital, Survival rate, Baptist Health South Florida, Disease, Phases of clinical research, MOS, Cancer, Texas Oncology, Massachusetts General Hospital, Survival, Manuscript, Journal, Multimedia, IIA, GBM, MBA, Pharmaceutical industry, Medical imaging, Medical device, Glioblastoma

SurVaxM was developed to bring a paradigm shift to a field with few advancements in recent years.

Key Points: 
  • SurVaxM was developed to bring a paradigm shift to a field with few advancements in recent years.
  • MimiVax announces positive Phase 2A SurVaxM data in GBM, 2yr survival rate of 51%, published in JCO
    This multi-center, open label, single arm, phase IIa trial in adult patients with nGBM was approved by the institutional review boards at each of the participating hospitals [NCT02455557].
  • Of 63 patients enrolled, 60 (95.2%) remained progression-free 6 months after diagnosis to successfully reach the study primary endpoint.
  • "These promising results seen in the Phase IIa study compare favorably to the historical contemporary outcomes seen in glioblastoma.

New Jersey Franchised Auto Dealers Honored For Longtime Support of The Valerie Fund

Retrieved on: 
Thursday, December 1, 2022
Parenting, Hospitals, Automotive, General Automotive, Public Policy, Government, Healthcare Reform, Health, Consumer, Oncology, Abigail (name), Morristown Medical Center, Newark Beth Israel Medical Center, Organization, Overlook Medical Center, State, Multimedia, Hospital, Partnership, The Grove, Children's Oncology Group, Friends, Organic, Travel, Garden State, Communication, Marketing, TVF, Fund, Cancer, Monmouth Medical Center, PSA, Research, Valerie, Garden, Automotive industry, Sickle cell disease, Degenerative disease, Car dealership, Medicine

This event raised $1.1 million dollars in support of The Valerie Fund.

Key Points: 
  • This event raised $1.1 million dollars in support of The Valerie Fund.
  • The partnership between The Valerie Fund and New Jerseys franchised dealers began in 2014 and the support the fundraising efforts made by the dealership community has been remarkable.
  • The Valerie Fund Executive Director, Barry Kirschner said, We are so thankful for the support of NJ CAR and all the New Jersey car and truck dealers in helping the Valerie Fund serve its critical mission of providing individualized care at medical centers close to home.
  • The relationship dealers have had with The Valerie Fund is a testament to the incredible work the Fund does to support thousands of children and their families in New Jersey.

The Fannie E. Rippel Foundation Announces the Appointment of Former CDC Leader Becky Payne as President and CEO; Alan Lieber, Former President of Overlook Medical Center, Named COO and Chief Health Care Strategist

Retrieved on: 
Thursday, September 15, 2022
Bethel Community Transformation Center, Workforce, Cornell College, Child, Michigan State University, Movement, Tropical medicine, Woman, Foundation, Cornell University, Organization, Retirement, Population, Chairperson, COO, Maintenance, Strategic planning, Government, Patient, Degenerative disease, Fellow, Cancer, Thought, CEO, BS, Quality of life, MBA, Public health, CDC, Leadership, Long-term care, Tulane University School of Public Health and Tropical Medicine, Patient safety, Public policy, Commerce, Overlook Medical Center, Rippel, Tulane School of Architecture, Gateway, Hospital, Multimedia, Ecology, Fannie, Atlantic Health System, Management, Medicine, Pharmaceutical industry, Health

MORRISTOWN, N.J., Sept. 15, 2022 /PRNewswire/ -- The Fannie E. Rippel Foundation (the "Foundation" or "Rippel"), a nonprofit operating foundation dedicated to fostering a future of equitable health and well-being for all, has announced the appointment of Becky Payne as President and CEO, effective January 1, 2023. At that time, Alan Lieber will assume the role of Chief Operating Officer (COO) and Chief Health Care Strategist. Laura Landy, who has served as the Foundation's President and CEO since 2006, will become President Emeritus and Senior Fellow and plans to retire at the end of 2023. Under Laura's leadership, the Foundation has increasingly become a national thought leader and advisor in working toward a more sustainable health system that ensures all people can thrive.

Key Points: 
  • At that time, Alan Lieber will assume the role of Chief Operating Officer (COO) and Chief Health Care Strategist.
  • Rippel's new leadership will advance its work as a catalyst for an equitable future for health and well-being.
  • The complementary talents and experiences brought by Becky and Alan are precisely what we hoped to find," said Edward W. Ahart, Esq., Board Chair, The Fannie E. Rippel Foundation.
  • Mr. Lieber is a leader in health care system innovation, with a focus on improved outcomes for patients and communities.